Cipla gains on partner's contract win
Reuters Market Eye - Shares in drugmaker Cipla(CIPL.NS) rise 1.4 percent after Cipla Medpro CMPJ.J won a share in South Africa's $667 million contract, as it supplies the bulk of Cipla Medpro's drugs.
Dealers say the company may garner revenues of $30-40 million from Cipla Medpro's contract.
South Africa on Thursday awarded a $667 million contract to supply life-prolonging HIV medicine to 12 international and domestic firms, including Cipla Medpro, to deal with its biggest health problem.
Cipla also plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic versions of branded drugs.
- Tweet this
- Share this
- Digg this
- TCS net profit rises 51.5 percent, sees stronger sales growth
- Hundreds of earthquakes strike central Idaho, rattling nerves
- Ocean floor search for missing Malaysia plane cut short again
- Search resumes for hundreds missing in S. Korean ferry disaster
- Syria says vehicles hit by Jordanian Air Force are not Syrian Army
Prime ministerial frontrunner Narendra Modi said he was committed to a policy of no first use of nuclear weapons, seeking to assuage concern after his Hindu nationalist BJP party vowed to revise the nuclear doctrine if elected to power. Full Article